View |
|
DR-XY15811
|
Ambroxol hydrochloride
|
Myracof
|
30mg per 5mL
|
Syrup
|
Mucolytic
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
29 April 2022
|
04 January 2027
|
View |
|
DR-XY15819
|
Survanta
|
Beractant
|
25 mg/mL
|
Suspension For Intratracheal Administration
|
-
|
Abbvie, Inc.
|
U.S.A.
|
-
|
11 March 2021
|
10 December 2025
|
View |
|
DR-XY15861
|
Cefixime
|
Tergecef
|
100 mg
|
Capsule
|
Antibacterial (Cephalosporin)
|
Asian Antibiotics, Inc
|
Philippines
|
Renewal
|
02 March 2024
|
22 April 2029
|
View |
|
DR-XY15883
|
Paracetamol+Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
|
Neo-Bromexan Forte
|
See Annex C
|
Capsule
|
Analgesic/Decongestant/Antihistamine
|
Medi-Rx Incoporated
|
Philippines
|
Renewal
|
24 January 2024
|
03 March 2029
|
View |
|
DR-XY15906
|
Fluticasone Propionate
|
Flixotide
|
50 mcg/actuation
|
Aqueous Nasal Spray
|
-
|
Glaxo Wellcome S.A.
|
Spain
|
-
|
21 May 2021
|
08 April 2026
|
View |
|
DR-XY15964
|
Cefalexin (As Monohydrate)
|
Respinal
|
250 mg/5mL
|
GRANULES FOR SUSPENSION
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
25 September 2020
|
09 October 2025
|
View |
|
DR-XY1597
|
Paracetamol
|
Teramol
|
500 mg
|
Tablet
|
-
|
Drugmaker's laboratories, Inc
|
Philippines
|
-
|
11 August 2020
|
12 October 2025
|
View |
|
DR-XY1599
|
Acyclovir
|
Zovirax
|
250 mg
|
Powder for Intravenous (IV) Infusion
|
-
|
GlaxoSmithKline Manufacturing S.P.A.
|
Italy
|
Initial (Variation)
|
12 May 2022
|
08 November 2024
|
View |
DR-XY15999_PI_01.pdf
|
DR-XY15999
|
Terbinafine (As Hydrochloride)
|
Lamisil
|
250 mg
|
Tablet
|
Antifungal
|
Novartis Pharma Produktions GmbH
|
Germany
|
Automatic Renewal
|
10 October 2022
|
30 October 2027
|
View |
|
DR-XY16012
|
Flucloxacillin
(As Sodium)
|
Stafloxin
|
250 mg
|
Capsule
|
-
|
Asian Antibiotics, Inc.
|
Philippines
|
-
|
07 May 2021
|
08 February 2026
|
View |
|
DR-XY16013
|
Flucloxacillin (As Sodium)
|
Stafloxin
|
500 mg
|
Capsule
|
-
|
Asian Antibiotics, Inc.
|
Philippines
|
-
|
04 December 2020
|
08 February 2026
|
View |
|
DR-XY16016
|
Tramadol hydrochloride
|
TDL
|
50 mg
|
Capsule
|
Opioid Analgesic
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
23 March 2023
|
09 October 2028
|
View |
|
DR-XY16022
|
Dextromethorphan Hydrobromide + Guaifenesin + Sodium Citrate + Phenylpropanolamine Hydrochloride
|
Dynatussin
|
10mg/50mg/150mg/10mg per 5mL
|
Syrup
|
-
|
SwissPharma Research Laboratories Inc.
|
Philippines
|
-
|
25 June 2020
|
13 September 2025
|
View |
|
DR-XY16055
|
Paroxetine
|
Seroxat
|
20mg
|
Tablet
|
Anti-depressant
|
S.C. Europharm S. A.
|
Brasov
|
Renewal
|
21 March 2022
|
16 February 2027
|
View |
|
DR-XY16063-B
|
Cotrimoxazole
|
Triphimox
|
400 mg/80 mg per 5 mL
|
Suspension
|
Antibacterial (Sulfonamide)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
13 December 2022
|
03 January 2028
|
View |
|
DR-XY16073
|
Cefalexin (as Monohydrate)
|
None
|
500mg
|
Capsule
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 February 2022
|
04 April 2027
|
View |
|
DR-XY16088
|
Cotrimoxazole
|
None
|
400 mg / 80 mg
|
Capsule
|
Antibacterial (Sulfonamide)
|
Drugmakers Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
19 May 2023
|
21 May 2028
|
View |
|
DR-XY16090
|
Cefuroxime (As Sodium)
|
Zinacef
|
250mg
|
Powder For Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
ACS Dobfar S.p.A.
|
Italy
|
-
|
02 March 2021
|
02 March 2026
|
View |
|
DR-XY16116
|
Amoxicillin (As Trihydrate)
|
Gexcil
|
250 mg / 5 mL
|
Granules For Suspension
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
01 August 2019
|
08 June 2024
|
View |
|
DR-XY16118
|
Ceftazidime (As Pentahydrate)
|
Fortum
|
500mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial
|
GlaxoSmithKline Manufacturing S.p.A
|
Italy
|
-
|
24 October 2019
|
03 November 2024
|